A61P 3/14

Sub-Class

Watch

Stats

Description

Class  A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS


Subclass 3/14: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for electrolyte homeostasis for calcium homeostasis (vitamin D A61P 3/02; parathyroid hormones A61P 5/18; calcitonin A61P 5/22; osteoporosis A61P 19/1; bone metastasis A61P 35/04)

Recent Patents

Patent #TitleFiling DateIssue DatePatent Owner
11959486 Stable liquid formulation of AMG 416 (etelcalcetide)Aug 11, 21Apr 16, 24Amgen Inc.
11932600 Biaryl derivativeOct 22, 19Mar 19, 24Daiichi Sankyo Company Limited; Sanford Burnham Prebys Medical Discovery Institute;
11911363 Ascorbate in the prevention of statin induced vascular calcificationJan 06, 23Feb 27, 24Not available
11793773 Methods and compositions for preventing or treating calciphylaxisJun 16, 21Oct 24, 23Epizon Pharma, Inc.
11737997 Method to increase cellular availability of calcium in skin cells and mixturesFeb 20, 20Aug 29, 23Merck Patent GmbH
11723919 Composition or combination comprising anionic dietary supplement and 25-hydroxy vitamin DJun 11, 21Aug 15, 23PHIBRO ANIMAL HEALTH CORPORATION
11723882 Methods and compositions for preventing or treating tissue calcificationMay 11, 21Aug 15, 23Epizon Pharma, Inc.
11590103 Ascorbate in the prevention of statin induced vascular calcificationMar 25, 21Feb 28, 23Not available
11590148 Use of calcifediol in bariatric surgery patientsApr 03, 19Feb 28, 23EIRGEN PHARMA LTD.
11547693 Ascorbate in the prevention of statin induced vascular calcificationJul 29, 19Jan 10, 23Not available
11331317 Composition for treating vascular or cardiac valvular calcification, containing thiamine derivativeJul 22, 19May 17, 22KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION
11162500 Stable liquid formulation of AMG 416 (etelcalcetide)Jun 03, 19Nov 02, 21Amgen Inc.
11065212 Methods and compositions for preventing or treating calciphylaxisJun 16, 20Jul 20, 21Epizon Pharma, Inc.
10987320 Methods and compositions for preventing or treating calciphylaxisJun 16, 20Apr 27, 21Epizon Pharma, Inc.
10940123 Methods and compositions for preventing or treating calciphylaxisJul 31, 20Mar 09, 21Epizon Pharma, Inc.
10925838 Methods and compositions for preventing or treating calciphylaxisJun 16, 20Feb 23, 21Epizon Pharma, Inc.
10829517 Method for treating or/and preventing calcium deficiency-related diseasesNov 14, 18Nov 10, 20National Chung Hsing University
10815257 Polymorph of sodium neridronate and preparation process thereofApr 10, 19Oct 27, 20Abiogen Pharma S.p.A.
10736858 Methods and compositions for preventing or treating calciphylaxisJun 07, 19Aug 11, 20Epizon Pharma, Inc.
10526358 Crystalline formsNov 12, 18Jan 07, 20THAR PHARMA, LLC

more results

Recent Publications

Publication #TitleFiling DatePub DatePatent Owner
2024/0041,794 METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING CALCIPHYLAXISAug 07, 23Feb 08, 24Not available
2024/0009,144 METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING TISSUE CALCIFICATIONJun 29, 23Jan 11, 24Not available
2023/0346,776 VETERINARY COMPOSITION FOR DAIRY RUMINANTS FOR TREATMENT OF MILK FEVERJan 26, 21Nov 02, 23Not available
2023/0144,808 ASCORBATE IN THE PREVENTION OF STATIN INDUCED VASCULAR CALCIFICATIONJan 06, 23May 11, 23Not available
2022/0000,766 PARENTERAL NUTRITION CONTAINING TRACE ELEMENTSJul 01, 21Jan 06, 22American Regent, Inc.
2019/0308,999 POLYMORPH OF SODIUM NERIDRONATE AND PREPARATION PROCESS THEREOFApr 10, 19Oct 10, 19Abiogen Pharma S.p.A.

more results

Top Owners in This Subclass

Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More

Patents Issued To Date - By Filing Year

Average Time to Issuance